Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma

被引：0
|
作者：
Chen, Ru [1 ]
Pan, Sheng [1 ]
Maitra, Anirban [2 ]
Simeone, Diane [3 ]
Dawson, David [4 ]
Brentnall, Teresa [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] UT MD Anderson, Houston, TX USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2866
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2866
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia
    Umesh K Bhanot
    Hepatobiliary & Pancreatic Diseases International, 2008, (01) : 106 - 107
  • [22] Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia
    Bhanot, Umesh K.
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2008, 7 (01) : 106 - 107
  • [23] Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
    Knipper, Karl
    Damanakis, Alexander I.
    Zhao, Yue
    Bruns, Christiane J.
    Schmidt, Thomas
    Popp, Felix C.
    Quaas, Alexander
    Lyu, Su Ir
    CANCERS, 2023, 15 (07)
  • [24] Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma
    Izumo, Wataru
    Higuchi, Ryota
    Furukawa, Toru
    Yazawa, Takehisa
    Uemura, Shuichirou
    Shiihara, Masahiro
    Yamamoto, Masakazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 780 - 786
  • [25] Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma
    Joliat, Gaetan-Romain
    Labgaa, Ismail
    Gilgien, Jerome
    Demartines, Nicolas
    PANCREAS, 2021, 50 (01) : 104 - 110
  • [26] Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?
    Reni, Michele
    Macchini, Marina
    Orsi, Giulia
    JAMA ONCOLOGY, 2022, 8 (12) : 1851 - 1851
  • [27] Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
    Dopico, Pablo J.
    Le, Minh-Chau N.
    Burgess, Benjamin
    Yang, Zhijie
    Zhao, Yu
    Wang, Youxiang
    George, Thomas J.
    Fan, Z. Hugh
    BIOSENSORS-BASEL, 2022, 12 (04):
  • [28] Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
    Kim, Dong Wook
    Ahn, Hyemin
    Kim, Kyung Won
    Lee, Seung Soo
    Kim, Hwa Jung
    Ko, Yousun
    Park, Taeyong
    Lee, Jeongjin
    KOREAN JOURNAL OF RADIOLOGY, 2022, 23 (11) : 1055 - 1066
  • [29] Long-term survival of patients receiving multimodality neoadjuvant therapy for resectable or borderline resectable pancreatic ductal adenocarcinoma
    McCormick, Kinsey
    Whiting, Samuel H.
    Gyurkey, Grace
    Koh, Wui-Jin
    Sinanan, Mika
    Coveler, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [30] Pancreatic Fat Accumulation Impacts Postoperative Survival in Patients With Pancreatic Ductal Adenocarcinoma
    Fukuda, Yasunari
    Koga, Chikato
    Minami, Soichiro
    Ishikawa, Satoshi
    Gakuhara, Atsushi
    Fukuda, Shuichi
    Haraguchi, Naotsugu
    Hida, Jinichi
    Wakasa, Tomoko
    Kimura, Yutaka
    WORLD JOURNAL OF SURGERY, 2025,
12345